Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Im Seop Choi
Inhibitory Effect of 4-O-Methylhonokiol on Lipopolysaccharide-Induced Neuroinflammation, Amyloidogenesis and Memory Impairment via Inhibition of Nuclear Factor-kappaB in Vitro and in Vivo Models
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
Related publications
Neonatal Infection-Induced Memory Impairment After Lipopolysaccharide in Adulthood Is Prevented via Caspase-1 Inhibition
Journal of Neuroscience
Neuroscience
Neuroinflammation Induced by Lipopolysaccharide Causes Cognitive Impairment in Mice
Scientific Reports
Multidisciplinary
Inhibition of HDAC6 Alleviating Lipopolysaccharide-Induced P38MAPK Phosphorylation and Neuroinflammation in Mice
Pharmaceutical Biology
Molecular Medicine
Pharmacology
Complementary
Alternative Medicine
Pharmaceutical Science
Medicine
Drug Discovery
In Vitro Evaluation of Inhibitory Effect of Nuclear Factor-KappaB Activity by Small Interfering RNA on Pro-Tumor Characteristics of M2-Like Macrophages
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Protective Effects of Phyllanthus Amarus Against Lipopolysaccharide-Induced Neuroinflammation and Cognitive Impairment in Rats
Frontiers in Pharmacology
Pharmacology
Calcineurin/Nuclear Factor-κB Signaling Mediates Isoflurane-Induced Hippocampal Neuroinflammation and Subsequent Cognitive Impairment in Aged Rats
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Inhibition of DNA Methylation With Zebularine Alters Lipopolysaccharide-Induced Sickness Behavior and Neuroinflammation in Mice
Frontiers in Neuroscience
Neuroscience
Sitagliptin Attenuates Inflammatory Responses in Lipopolysaccharide-Stimulated Cardiomyocytes via Nuclear Factor-κB Pathway Inhibition
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
The Activity of Antiparkinsonian Drug Hemantane in Models of Peripheral Inflammation and Lipopolysaccharide-Induced Neuroinflammation
Advances in Parkinson's Disease
